Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1968 Aug;47(8):1806–1818. doi: 10.1172/JCI105870

Effect of neomycin on exchangeable pools of cholesterol in the steady state

Paul Samuel 1,2, Charles M Holtzman 1,2, Edward Meilman 1,2, William Perl 1,2
PMCID: PMC297340  PMID: 4875006

Abstract

Five patients received cholesterol-7α-3H intravenously during control periods. Specific activity of total serum cholesterol was determined serially during the 1st wk and weekly thereafter. 28-59 wk after the injection of the tracer, when no further radioactivity could be detected in serum cholesterol, 2 g of oral neomycin was given daily to four patients for the remainder of the experiment. Average total serum cholesterol concentrations were reduced by 20, 21, 26, and 29%, respectively, in these subjects. The fifth patient, given placebo, had no change in serum cholesterol. After a period of 12-26 wk of medication the intravenous injection of cholesterol-7α-3H was repeated, and while neomycin or placebo administration was continued, serum cholesterol specific activity was again determined serially during the 1st wk and weekly thereafter for 23-42 wk. The data were subjected to a two-compartment analysis. During the administration of neomycin, half-times of the cholesterol radio-activity decay curves were decreased in two patients and remained unchanged in two subjects. The size of the “intermediate” pool of cholesterol decreased in each patient during the administration of neomycin by 33, 36, 40, and 44%, respectively. The absolute decrease was much larger in each case than the concomitant reduction of serum cholesterol. There was no significant change in the data during the administration of placebo in one patient. The size of the “intermediate” pool can be calculated by compartmental analysis from the cholesterol decay curves. For the “slow” pool size and the other kinetic parameters only ranges of values can be deduced from the present experiment.

Full text

PDF
1806

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABEL L. L., LEVY B. B., BRODIE B. B., KENDALL F. E. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952 Mar;195(1):357–366. [PubMed] [Google Scholar]
  2. AYERS C. R., DAVIS J. O., LIEBERMAN F., CARPENTER C. C., BERMAN M. The effects of chronic hepatic venous congestion on the metabolism of d,1-aldosterone and d-aldosterone. J Clin Invest. 1962 Apr;41:884–895. doi: 10.1172/JCI104545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Avigan J., Steinberg D. Sterol and bile acid excretion in man and the effects of dietary fat. J Clin Invest. 1965 Nov;44(11):1845–1856. doi: 10.1172/JCI105292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CHOBANIAN A. V., BURROWS B. A., HOLLANDER W. Body cholesterol metabolism in man. II. Measurement of the body cholesterol miscible pool and turnover rate. J Clin Invest. 1962 Sep;41:1738–1744. doi: 10.1172/JCI104632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GOULD R. G., LEROY G. V., OKITA G. T., KABARA J. J., KEEGAN P., BERGENSTAL D. M. The use of C14-labeled acetate to study cholesterol metabolism in man. J Lab Clin Med. 1955 Sep;46(3):372–384. [PubMed] [Google Scholar]
  6. GURPIDE E., MANN J., SANDBERG E. DETERMINATION OF KINETIC PARAMETERS INA TWO-POOL SYSTEM BY ADMINISTRATION OF ONE OR MORE TRACERS. Biochemistry. 1964 Sep;3:1250–1255. doi: 10.1021/bi00897a012. [DOI] [PubMed] [Google Scholar]
  7. Goodman D. S. Cholesterol ester metabolism. Physiol Rev. 1965 Oct;45(4):747–839. doi: 10.1152/physrev.1965.45.4.747. [DOI] [PubMed] [Google Scholar]
  8. Goodman D. S., Noble R. P. Turnover of plasma cholesterol in man. J Clin Invest. 1968 Feb;47(2):231–241. doi: 10.1172/JCI105719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HELLMAN L., ROSENFELD R. S., EIDINOFF M. L., FUKUSHIMA D. K., GALLAGHER T. F., WANG C. I., ADLERSBERG D. Isotopic studies of plasma cholesterol of endogenous and exogenous origins. J Clin Invest. 1955 Jan;34(1):48–60. doi: 10.1172/JCI103062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HELLMAN L., ROSENFELD R. S., GALLAGHER T. F. Cholesterol synthesis from C14-acetate in man. J Clin Invest. 1954 Feb;33(2):142–149. doi: 10.1172/JCI102881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. KURLAND G. S., LUCAS J. L., FREEDBERG A. S. The metabolism of intravenously infused C14-labeled cholesterol in euthyroidism and myxedema. J Lab Clin Med. 1961 Apr;57:574–585. [PubMed] [Google Scholar]
  12. LEROY G. V. Studies of cholesterol synthesis in man using carbon labeled acetate. Ann Intern Med. 1956 Mar;44(3):524–533. doi: 10.7326/0003-4819-44-3-524. [DOI] [PubMed] [Google Scholar]
  13. LONDON I. M., RITTENBERG D. Deuterium studies in normal man. I. The rate of synthesis of serum cholesterol. II. Measurement of total body water and water absorption. J Biol Chem. 1950 Jun;184(2):687–691. [PubMed] [Google Scholar]
  14. POWELL R. C., NUNES W. T., HARDING R. S., VACCA J. B. The influence of nonabsorbable antibiotics on serum lipids and the excretion of neutral sterols and bile acids. Am J Clin Nutr. 1962 Aug;11:156–168. doi: 10.1093/ajcn/11.2.156. [DOI] [PubMed] [Google Scholar]
  15. SAMUEL P. Effect of neomycin, para-aminosalicylic-acid and other antibacterial drugs on serum cholesterol level of man. Proc Soc Exp Biol Med. 1959 Oct;102:194–196. doi: 10.3181/00379727-102-25188. [DOI] [PubMed] [Google Scholar]
  16. SAMUEL P., STEINER A. Effect of neomycin on serum cholesterol level of man. Proc Soc Exp Biol Med. 1959 Jan;100(1):193–195. doi: 10.3181/00379727-100-24569. [DOI] [PubMed] [Google Scholar]
  17. SAMUEL P., WHITHE W. I. Reduction of serum cholesterol concentrations by neomycin, para-aminosalicylic acid, and other antibacterial drugs in man. Circulation. 1961 Sep;24:578–591. doi: 10.1161/01.cir.24.3.578. [DOI] [PubMed] [Google Scholar]
  18. SKINNER S. M., CLARK R. E., BAKER N., SHIPLEY R. A. Complete solution of the three-compartment model in steady state after single injection of radioactive tracer. Am J Physiol. 1959 Feb;196(2):238–244. doi: 10.1152/ajplegacy.1959.196.2.238. [DOI] [PubMed] [Google Scholar]
  19. SPRITZ N., AHRENS E. H., Jr, GRUNDY S. STEROL BALANCE IN MAN AS PLASMA CHOLESTEROL CONCENTRATIONS ARE ALTERED BY EXCHANGES OF DIETARY FATS. J Clin Invest. 1965 Sep;44:1482–1493. doi: 10.1172/JCI105255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Samuel P., Holtzman C. M., Goldstein J. Long-term reduction of serum cholesterol levels of patients with atherosclerosis by small doses of neomycin. Circulation. 1967 May;35(5):938–945. doi: 10.1161/01.cir.35.5.938. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES